Home / First Trust / FIRST TRUST EXCHANGE-TRADED FUND VI / First Trust Nasdaq Pharmaceuticals ETF
First Trust Nasdaq Pharmaceuticals ETF
A series of FIRST TRUST EXCHANGE-TRADED FUND VI
- Vote records
- 539year to 30 June 2025
- Against management
- 7.6%41 of 539 marked votes
- Say-on-pay support
- 90.7%for, of for + against + abstain
- Shareholder-proposal support
- 13.6%for, of for + against + abstain
First Trust Nasdaq Pharmaceuticals ETF is a series of FIRST TRUST EXCHANGE-TRADED FUND VI. For the year to 30 June 2025 its registrant reported 539 vote records for the series; 7.6% of the votes marked for or against management went against management. It voted for 90.7% of say-on-pay items and for 13.6% of proposals from security holders.
Compared with its registrant and family
| year to 30 June 2025 | This series | Its registrant | First Trust | Median fund registrant |
|---|---|---|---|---|
| Against-management share | 7.6% | 6.4% | 7.7% | 6.1% |
| Say-on-pay support rate | 90.7% | 90.6% | 86.8% | 91.3% |
| Shareholder-proposal support rate | 13.6% | 25.1% | 27.0% | 23.5% |
Votes by category
foragainstabstain, withhold or otheramber tick: the portion cast against management
| Category (as the form names it) | Votes | For | Against | Against management | Split |
|---|---|---|---|---|---|
| DIRECTOR ELECTIONS | 355 | 327 | 3 | 7.9% | |
| SECTION 14A SAY-ON-PAY VOTES | 62 | 50 | 5 | 8.1% | |
| AUDIT-RELATED | 52 | 52 | 0 | 0.0% | |
| SHAREHOLDER RIGHTS AND DEFENSES | 2 | 2 | 0 | 0.0% | |
| EXTRAORDINARY TRANSACTIONS | 2 | 2 | 0 | 0.0% | |
| CAPITAL STRUCTURE | 6 | 6 | 0 | 0.0% | |
| COMPENSATION | 28 | 22 | 6 | 17.9% | |
| CORPORATE GOVERNANCE | 20 | 14 | 6 | 15.0% | |
| ENVIRONMENT OR CLIMATE | 6 | 0 | 6 | 0.0% | |
| HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE | 3 | 0 | 3 | 0.0% | |
| DIVERSITY, EQUITY, AND INCLUSION | 7 | 0 | 7 | 0.0% | |
| OTHER SOCIAL ISSUES | 8 | 0 | 8 | 0.0% |
By season
| Season | Vote records | Against management | Say-on-pay support | Shareholder-proposal support |
|---|---|---|---|---|
| year to 30 June 2024 | 541 | 11.8% | 90.2% | 26.9% |
| year to 30 June 2025 | 539 | 7.6% | 90.7% | 13.6% |
Questions
How often did First Trust Nasdaq Pharmaceuticals ETF vote against management?
7.6% of the votes its registrant marked for or against management in the year to 30 June 2025 (41 of 539).
How did First Trust Nasdaq Pharmaceuticals ETF vote on executive pay?
It voted for 49 of 54 say-on-pay items cast for, against or abstain (90.7%).
Is this the result of the meetings?
No. Form N-PX shows how the fund voted the shares it held. It does not show how other shareholders voted or what the outcome was.
Where does the data come from?
From the Form N-PX filed by FIRST TRUST EXCHANGE-TRADED FUND VI, which lists the series that cast each vote. The SEC does not verify the contents. Data runs through 23 Sep 2026.
Provenance: SEC EDGAR, Form N-PX filed by FIRST TRUST EXCHANGE-TRADED FUND VI (filer no. 1552740); votes attributed to series S000053945 by the filer. Not verified by the SEC. Filings read through 23 Sep 2026.